vortioxetine (as vortioxetine hydrobromide) 5 MG Oral Tablet
- RxCUI
- 1439812
- RxNorm name
- vortioxetine (as vortioxetine hydrobromide) 5 MG Oral Tablet
- Display name
- vortioxetine (as vortioxetine hydrobromide) 5 MG Oral Tablet
- Full name
- vortioxetine (as vortioxetine hydrobromide) 5 MG Oral Tablet
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:49
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Trintellix | VORTIOXETINE | REMEDYREPACK INC. | bd0107e5-1cb9-4b40-a6af-fa65fcbe6b4e | 2026-04-23 | Boxed warning, Warnings, Adverse reactions | 1439812 |
| Trintellix | VORTIOXETINE | Takeda Pharmaceuticals America, Inc. | 1a5b68e2-14d0-419d-9ec6-1ca97145e838 | 2025-03-05 | Boxed warning, Warnings, Adverse reactions | 1439812 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 1a5b68e2-14d0-419d-9ec6-1ca97145e838 | vortioxetine 5 MG Oral Tablet | PSN | 18 | These highlights do not include all the information needed to use TRINTELLIX ® safely and effectively. See full prescribing information for TRINTELLIX. TRINTELLIX (vortioxetine) tablets, for oral use Initial U.S. Approval: 2013 | 20250305 |
| 1a5b68e2-14d0-419d-9ec6-1ca97145e838 | vortioxetine 5 MG Oral Tablet | SCD | 18 | These highlights do not include all the information needed to use TRINTELLIX ® safely and effectively. See full prescribing information for TRINTELLIX. TRINTELLIX (vortioxetine) tablets, for oral use Initial U.S. Approval: 2013 | 20250305 |
| 1a5b68e2-14d0-419d-9ec6-1ca97145e838 | vortioxetine (as vortioxetine hydrobromide) 5 MG Oral Tablet | SY | 18 | These highlights do not include all the information needed to use TRINTELLIX ® safely and effectively. See full prescribing information for TRINTELLIX. TRINTELLIX (vortioxetine) tablets, for oral use Initial U.S. Approval: 2013 | 20250305 |
| bd0107e5-1cb9-4b40-a6af-fa65fcbe6b4e | vortioxetine (as vortioxetine hydrobromide) 5 MG Oral Tablet | SY | 2 | These highlights do not include all the information needed to use TRINTELLIX ® safely and effectively. See full prescribing information for TRINTELLIX. TRINTELLIX (vortioxetine) tablets, for oral use Initial U.S. Approval: 2013 | 20260423 |
| bd0107e5-1cb9-4b40-a6af-fa65fcbe6b4e | vortioxetine 5 MG Oral Tablet | SCD | 2 | These highlights do not include all the information needed to use TRINTELLIX ® safely and effectively. See full prescribing information for TRINTELLIX. TRINTELLIX (vortioxetine) tablets, for oral use Initial U.S. Approval: 2013 | 20260423 |
| bd0107e5-1cb9-4b40-a6af-fa65fcbe6b4e | vortioxetine 5 MG Oral Tablet | PSN | 2 | These highlights do not include all the information needed to use TRINTELLIX ® safely and effectively. See full prescribing information for TRINTELLIX. TRINTELLIX (vortioxetine) tablets, for oral use Initial U.S. Approval: 2013 | 20260423 |